Archivos espanoles de urologia · 2026
Radiologic and Lipid Metabolism Imaging Features Associated with FABP2 Expression in Clear Cell Renal Cell Carcinoma: An Interpretable Supervised Machine Learning Radiogenomic Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Greco Federico, Cataldo Marco, Panunzio Andrea, Tafuri Alessandro, Beomonte Zobel Bruno, Mallio Carlo Augusto
Аннотация
BACKGROUND: This study investigated the association between computed tomography (CT) features and fatty acid-binding protein 2 (FABP2) gene expression in clear cell renal cell carcinoma (ccRCC), focusing on morphologic and metabolic parameters.
METHODS: A retrospective analysis was performed on 246 ccRCC patients from The Cancer Genome Atlas (TCGA) and The Cancer Imaging Archive (TCIA). Patients were classified as FABP2-positive (n = 57, 23.17%) or FABP2-negative (n = 189, 76.83%). Clinical, pathological, and imaging features were compared. Quantitative CT assessed mean tumor attenuation and abdominal adipose compartments. Two logistic regression models were built: one based on radiologic features and one on metabolic imaging parameters.
RESULTS: FABP2-positive tumors were significantly smaller, more frequently low-grade and diagnosed at an earlier stage. FABP2 expression was more common in male patients. On imaging, FABP2-negative tumors more often exhibited collateral vascular supply. Quantitative CT revealed lower mean attenuation in FABP2-positive tumors, suggesting higher intracellular lipid content. No significant differences were found in hepatic attenuation or abdominal adipose compartments. The radiologic model achieved an area under the curve (AUC) of 0.58, with cystic composition as the strongest predictor of FABP2 positivity. The lipid metabolism-based model showed slightly better performance (AUC 0.61), with mean tumor attenuation as the most influential variable.
CONCLUSIONS: FABP2-positive ccRCC appears to represent a less aggressive, lipid-rich phenotype. CT attenuation features were weakly associated with FABP2 expression and may offer preliminary, noninvasive insights to support integrated radiogenomic approaches in ccRCC.
METHODS: A retrospective analysis was performed on 246 ccRCC patients from The Cancer Genome Atlas (TCGA) and The Cancer Imaging Archive (TCIA). Patients were classified as FABP2-positive (n = 57, 23.17%) or FABP2-negative (n = 189, 76.83%). Clinical, pathological, and imaging features were compared. Quantitative CT assessed mean tumor attenuation and abdominal adipose compartments. Two logistic regression models were built: one based on radiologic features and one on metabolic imaging parameters.
RESULTS: FABP2-positive tumors were significantly smaller, more frequently low-grade and diagnosed at an earlier stage. FABP2 expression was more common in male patients. On imaging, FABP2-negative tumors more often exhibited collateral vascular supply. Quantitative CT revealed lower mean attenuation in FABP2-positive tumors, suggesting higher intracellular lipid content. No significant differences were found in hepatic attenuation or abdominal adipose compartments. The radiologic model achieved an area under the curve (AUC) of 0.58, with cystic composition as the strongest predictor of FABP2 positivity. The lipid metabolism-based model showed slightly better performance (AUC 0.61), with mean tumor attenuation as the most influential variable.
CONCLUSIONS: FABP2-positive ccRCC appears to represent a less aggressive, lipid-rich phenotype. CT attenuation features were weakly associated with FABP2 expression and may offer preliminary, noninvasive insights to support integrated radiogenomic approaches in ccRCC.